Biologics Market 2021 Next Big Thing | Novo Nordisk A/S, Pfizer Inc., Amgen, Sanofi, Samsung BioLogics, Merck & Co

Emergen Research Logo

Emergen Research Logo

Rising occurrences of target conditions and advancements in biomedical technology are among the significant factors influencing market revenue growth

Biologics Market Size โ€“ USD 299.72 Billion in 2020, Biologics Market Growth - CAGR of 8.4%, Biologics Market Trends โ€“Surging demand and higher adoption of novel therapies”
— Emergen Research

VANCOUER, BC, CANADA, July 28, 2022 /EINPresswire.com/ -- The global Biologics Market1 is projected to reach USD 567.96 Billion in 2028 at a steady revenue CAGR of 8.4% over the forecast period, according to latest analysis by Emergen Research. Some key factors attributed to steady market revenue growth include rising demand for monoclonal antibodies, recombinant hormones/proteins, gene-based & cellular-based biologics, vaccines, and molecular therapy, etc. in the treatment of diseases including cancer, infectious diseases, immunological diseases, cardiovascular diseases, and hematological diseases, among others. Also, rising use of biologics for the treatment of autoimmune diseases, comprising various arthritis types, including ankylosing spondylitis, rheumatoid arthritis, and psoriatic arthritis, is playing a crucial role in driving revenue growth of the global biologics market.

The Global Biologics Market Research Report provides a brief overview inclusive of the competitive landscape and key developments, policies, manufacturing costs, and processes. The report also provides the analysis of import/export, production and consumption ratio, supply and demand, cost, price, estimated revenue, and gross margins. The report further discusses in detail the driving factors influencing the growth of the market currently and in the coming years.

๐…๐จ๐ซ ๐‚๐ซ๐ข๐ญ๐ข๐œ๐š๐ฅ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ, ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐๐ซ๐จ๐œ๐ก๐ฎ๐ซ๐ž ๐š๐ญ @ https://www.emergenresearch.com/request-sample/61

Surging demand and higher adoption of novel biologics drugs and therapies across the globe for the treatment of disease conditions is a significant factor causative of steady market revenue growth. One such novel drug is Antibody-Drug Conjugate (ADC), which is a highly effective drug used in disease treatment. In cancer treatment, ADC delivers drugs to the disease/target cells with a very high specificity, thereby maximizing efficacy and lessening systemic exposure, as well as associated side effect risks. Based on payload attached to the antibody, ADC can be deployed to influence several biological functions.

๐Š๐ž๐ฒ ๐ช๐ฎ๐ž๐ฌ๐ญ๐ข๐จ๐ง๐ฌ ๐š๐๐๐ซ๐ž๐ฌ๐ฌ๐ž๐ ๐ข๐ง ๐ญ๐ก๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ:

What is the projected growth rate likely to be witnessed by each market region?
Which of the leading Biologics Market regions accounts for the maximum market share over the forecast years?
What sales estimates every region is expected to hold in the Biologics Market in the near future?
What is each regional segmentโ€™s current valuation?
What are the estimated remunerations of these regions over the forecast timeline?

๐’๐จ๐ฆ๐ž ๐Š๐ž๐ฒ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐Ÿ ๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ :

In September 2020, Biocon Biologics Ltd. and Mylan made an announcement about the introduction of biosimilar Semglee in the US. This biosimilar is available, both in pre-filled pen and vials, and is intended for controlling high blood pressure in adults having type 2 diabetes and pediatric patients having type 1 diabetes.

Among the source segments, mammalian segment revenue is expected to register a significantly rapid growth rate over forecast period. Expression systems deploying mammalian cells for recombinant hormones/proteins can introduce appropriate protein folding, PTM (post-translational modifications), and product assembly that are essential for overall biological activity.

Among the product type segments, vaccines segment revenue is expected to expand at a relatively faster rate over forecast period. A vaccine functions by preparing the immune system to identify and fight pathogens, either bacteria or viruses. Vaccines are beneficial in reducing preventable infectious diseases, and currently, fewer number individuals suffer from the distressing effects of pertussis and measles, among other illnesses. Presently, vaccines are witnessing spiraling demand across the globe to curb the spread of COVID-19 and resulting mortalities occurring due to the disease.

๐€๐ฌ๐ข๐š ๐๐š๐œ๐ข๐Ÿ๐ข๐œ ๐€๐œ๐œ๐จ๐ฎ๐ง๐ญ๐ž๐ ๐Ÿ๐จ๐ซ ๐‹๐š๐ซ๐ ๐ž๐ฌ๐ญ ๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž ๐’๐ก๐š๐ซ๐ž ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ—:

The market in Asia Pacific is expected to register fastest revenue CAGR over forecast period due to improving healthcare infrastructure, rising investments in biologics development, and better reimbursement scenario in some countries in the region.

๐’๐จ๐ฆ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ฉ๐ซ๐จ๐ฆ๐ข๐ง๐ž๐ง๐ญ ๐ฉ๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐จ๐ฉ๐ž๐ซ๐š๐ญ๐ข๐ง๐  ๐ข๐ง ๐ญ๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐š๐ซ๐ž:

Novo Nordisk A/S, Pfizer Inc., Amgen, Sanofi, Samsung BioLogics, Merck & Co. Inc., Celltrion, AbbVie Inc., Johnson & Johnson Services Inc., Eli Lilly & Company, F Hoffman La Roche, Addgene, Novartis AG, and GlaxoSmithKline.

๐“๐จ ๐ ๐ž๐ญ ๐š๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐จ ๐ญ๐ก๐ž ๐œ๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐จ๐ง ๐ญ๐ก๐ž ๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ , ๐œ๐ฅ๐ข๐œ๐ค ๐จ๐ง ๐ญ๐ก๐ž ๐ฅ๐ข๐ง๐ค ๐ฆ๐ž๐ง๐ญ๐ข๐จ๐ง๐ž๐ ๐ก๐ž๐ซ๐ž: @ https://www.emergenresearch.com/industry-report/biologics-market

The report on the Global Biologics Market initially offers an in-depth overview of the Biologics Market along with insights into the developments and advancements in the sector. The report offers a comprehensive overview of the regional and competitive landscape and provides a deeper insight into the current market scenario and future growth prospects. The research study also provides a complete analysis of the market drivers, restraints, limitations, threats, risks, and growth opportunities.

๐•๐š๐ฅ๐ฎ๐š๐›๐ฅ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:

The report highlights the latest trends observed in the consumption pattern of each regional segment.
Extensive market segmentation included in the report helps better understand the revenue and estimated growth of the individual regions.
The report throws light on the historical and current market scenarios and provides a concise year-on-year growth rate of the Biologics Market .
The report further entails the current market trends, technological advancements, revenue growth, and other aspects affecting market growth.

To Gain In-Depth Insights on biologics market, Request Methodology at2

๐„๐ฆ๐ž๐ซ๐ ๐ž๐ง ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ก๐š๐ฌ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ž๐ ๐ญ๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐›๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐ฌ ๐จ๐ง ๐ญ๐ก๐ž ๐›๐š๐ฌ๐ข๐ฌ ๐จ๐Ÿ ๐ฌ๐จ๐ฎ๐ซ๐œ๐ž, ๐ฉ๐ซ๐จ๐๐ฎ๐œ๐ญ ๐ญ๐ฒ๐ฉ๐ž, ๐š๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง, ๐š๐ง๐ ๐ซ๐ž๐ ๐ข๐จ๐ง:

๐’๐จ๐ฎ๐ซ๐œ๐ž ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž, ๐”๐’๐ƒ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง; ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ–-๐Ÿ๐ŸŽ๐Ÿ๐Ÿ–)
Microbial
Mammalian
Others

๐๐ซ๐จ๐๐ฎ๐œ๐ญ ๐“๐ฒ๐ฉ๐ž ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž, ๐”๐’๐ƒ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง; ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ–-๐Ÿ๐ŸŽ๐Ÿ๐Ÿ–)
Monoclonal Antibodies
Vaccines
Recombinant Hormones/Proteins
Cellular-Based Biologics
Gene-Based Biologics
Others

๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž, ๐”๐’๐ƒ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง; ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ–-๐Ÿ๐ŸŽ๐Ÿ๐Ÿ–)
Cancer
Infectious Diseases
Immunological Diseases
Cardiovascular Diseases
Hematological Disorders
Others

๐‚๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐‚๐จ๐ฏ๐ž๐ซ๐ฌ ๐ญ๐ก๐ž ๐…๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐  ๐‘๐ž๐ ๐ข๐จ๐ง๐ฌ:

North America (U.S., Canada, Mexico)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ @ https://www.emergenresearch.com/request-for-customization/61

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐ฆ๐จ๐ซ๐ž ๐ซ๐ž๐ฅ๐š๐ญ๐ž๐ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ@

Artificial Intelligence in Cancer Diagnosis and Therapy Market

https://www.emergenresearch.com/industry-report/artificial-intelligence-in-cancer-diagnosis-and-therapy-market

Sulfate Free Shampoo Market

https://www.emergenresearch.com/industry-report/sulfate-free-shampoo-market

Remote Lawn Mower Market

https://www.emergenresearch.com/industry-report/remote-lawn-mower-market

Automated Blood Collection Market

https://www.emergenresearch.com/industry-report/automated-blood-collection-market

Security Information and Event Management Market

https://www.emergenresearch.com/industry-report/security-information-and-event-management-market

Feed Enzymes Market

https://www.emergenresearch.com/industry-report/feed-enzymes-market

๐€๐›๐จ๐ฎ๐ญ ๐ฎ๐ฌ:

Emergen research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help clientโ€™s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn

1 https://www.emergenresearch.com/industry-report/biologics-market
2 https://www.emergenresearch.com/request-sample/61

This press release can be viewed online at: https://www.einpresswire.com/article/583416235/

Disclaimer: If you have any questions regarding information in this press release please contact the company listed in the press release. Please do not contact EIN Presswire. We will be unable to assist you with your inquiry. EIN Presswire disclaims any content contained in these releases.

© 1995-2024 Newsmatics Inc. All Right Reserved.